These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31806858)

  • 1. The rise of disposable JUUL-type e-cigarette devices.
    Williams R
    Tob Control; 2020 Dec; 29(e1):e134-e135. PubMed ID: 31806858
    [No Abstract]   [Full Text] [Related]  

  • 2. E-cigarette flavour enhancers: Flavoured pod attachments compatible with JUUL and other pod-based devices.
    Cwalina SN; Leventhal AM; Barrington-Trimis JL
    Tob Control; 2020 Dec; 29(e1):e127-e128. PubMed ID: 32273434
    [No Abstract]   [Full Text] [Related]  

  • 3. Dependence and Use Characteristics of Adult JUUL Electronic Cigarette Users.
    Yingst J; Foulds J; Hobkirk AL
    Subst Use Misuse; 2021; 56(1):61-66. PubMed ID: 33118854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal trends in e-cigarette devices used by Californian youth, 2014-2018.
    Lin C; Baiocchi M; Halpern-Felsher B
    Addict Behav; 2020 Sep; 108():106459. PubMed ID: 32388394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. College Students' Reasons for Using JUULs.
    Newcombe KV; Dobbs PD; Oehlers JS; Dunlap CM; Cheney MK
    Am J Health Promot; 2021 Jul; 35(6):835-840. PubMed ID: 33535769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of JUUL E-cigarettes Among Youth in the United States.
    Hammond D; Wackowski OA; Reid JL; O'Connor RJ
    Nicotine Tob Res; 2020 Apr; 22(5):827-832. PubMed ID: 30371838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Public Health Crisis: Electronic Cigarettes, Vape, and JUUL.
    Walley SC; Wilson KM; Winickoff JP; Groner J
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31122947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young Adult JUUL Users' Beliefs About JUUL.
    Cheney MK; Dobbs PD; Dunlap C; Lu Y; Oehlers J; Hodges E
    J Adolesc Health; 2021 Jan; 68(1):138-145. PubMed ID: 32654838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterising JUUL-related posts on Instagram.
    Czaplicki L; Kostygina G; Kim Y; Perks SN; Szczypka G; Emery SL; Vallone D; Hair EC
    Tob Control; 2020 Nov; 29(6):612-617. PubMed ID: 31266903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JUUL use and reasons for initiation among adult tobacco users.
    Patel M; Cuccia A; Willett J; Zhou Y; Kierstead EC; Czaplicki L; Schillo B; Hair EC; Vallone D
    Tob Control; 2019 Nov; 28(6):681-684. PubMed ID: 31217283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JUUL releases more nicotine in the first puffs.
    Salman R; Talih S; Karam E; Karaoghlanian N; Ashley DL; Shihadeh A
    Tob Control; 2023 Mar; 32(2):267-268. PubMed ID: 34257150
    [No Abstract]   [Full Text] [Related]  

  • 12. Parents support strong restrictions controlling e-cigarette use in Australia: findings from a national survey.
    Measey MA; Palit V; Hoq M; Vandeleur M; Rhodes A
    Tob Control; 2023 Aug; 32(e2):e265-e266. PubMed ID: 35581000
    [No Abstract]   [Full Text] [Related]  

  • 13. Philip Morris research on precursors to the modern e-cigarette since 1990.
    Dutra LM; Grana R; Glantz SA
    Tob Control; 2017 Dec; 26(e2):e97-e105. PubMed ID: 27852893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine arms race: JUUL and the high-nicotine product market.
    Jackler RK; Ramamurthi D
    Tob Control; 2019 Nov; 28(6):623-628. PubMed ID: 30733312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cigarette maker Juul will pay $462m to settle deceptive marketing allegations in six US states.
    Dyer O
    BMJ; 2023 Apr; 381():859. PubMed ID: 37068809
    [No Abstract]   [Full Text] [Related]  

  • 16. Surveillance of U.S. Corporate Filings Provides a Proactive Approach to Inform Tobacco Regulatory Research Strategy.
    Sarles SE; Hensel EC; Robinson RJ
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33809725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market.
    Huang J; Duan Z; Kwok J; Binns S; Vera LE; Kim Y; Szczypka G; Emery SL
    Tob Control; 2019 Mar; 28(2):146-151. PubMed ID: 29853561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived addiction to vaping among youth and young adult regular vapers.
    Camara-Medeiros A; Diemert L; O'Connor S; Schwartz R; Eissenberg T; Cohen JE
    Tob Control; 2021 May; 30(3):273-278. PubMed ID: 32198277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US FDA delays decision on Juul and other leading e-cigarette brands.
    Furlow B
    Lancet Respir Med; 2021 Dec; 9(12):e115. PubMed ID: 34559983
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid proliferation of illegal pod-mod disposable e-cigarettes.
    Delnevo C; Giovenco DP; Hrywna M
    Tob Control; 2020 Dec; 29(e1):e150-e151. PubMed ID: 32001606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.